Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-207066
Filing Date
2021-07-02
Accepted
2021-07-02 08:00:36
Documents
10
Period of Report
2021-08-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d180940ddef14a.htm DEF 14A 1130477
2 GRAPHIC g180940g11i11.jpg GRAPHIC 6983
3 GRAPHIC g180940g13d57.jpg GRAPHIC 15542
4 GRAPHIC g180940g20c01.jpg GRAPHIC 527
5 GRAPHIC g180940g21c02.jpg GRAPHIC 563
6 GRAPHIC g180940g22s10.jpg GRAPHIC 551
7 GRAPHIC g180940g23s20.jpg GRAPHIC 514
8 GRAPHIC g180940g24l25.jpg GRAPHIC 524
9 GRAPHIC g180940g70l14.jpg GRAPHIC 27430
10 GRAPHIC g180940g98u41.jpg GRAPHIC 28250
  Complete submission text file 0001193125-21-207066.txt   1243886
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1225
Type: DEF 14A | Act: 34 | File No.: 001-35803 | Film No.: 211068013
SIC: 2834 Pharmaceutical Preparations